Pharmaceutical Product Development, Llc And Neogenomics Laboratories, Inc Partnered To Molecular Testing Solution For Molecular Cytogenetics Market
In June 2018, Pharmaceutical Product Development, LLC (PPD), a global contract research organization (CRO), and NeoGenomics Laboratories, Inc., a provider of cancer-focused genetic testing services have formed a strategic alliance to offer a seamless and fully integrated global pathology and molecular testing solution to PPD’s pharmaceutical and biotech clients. The high burden of genetic disorders and cancer around the globe is propelling the growth of the molecular cytogenetics market . According to the National Institutes of Health, about 1 in 200,000 people in the United States are diagnosed with syndrome A each year. An estimated 15,000 people worldwide were diagnosed with syndrome B last year. The growing use of molecular cytogenetic products in academic research institutes, clinical and research laboratories, and pharmaceutical and biotechnology industries are again expected to uplift the growth of the market. Moreover, increasing activities in pharmacogenomics are also pro...